Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The combination is intended for patients who have previously received at least o...
The collaboration aims to develop new quantum algorithms that could accelerate t...
Platform brings regulatory intelligence, labelling, gap assessments, health aut...
Triggered by recent high profile operations involving counterfeit semaglutide i...
The decision marks the third NMPA-approved indication for an ivonescimab-contain...
The proceeds will also be used to fund Remepy’s lead product Hybridopa’s global ...
BASF’s Personal Care business introduces Floragenist Rose and Floragenist Bloss...
BIRAC’s pavilion features start-ups working on medical devices, rehabilitation ...
Stuart Preston explains how metal detection supports contamination control, pro...
The transaction is structured through a share purchase agreement with SEVER Life...
The arrangement enables Sentynl to acquire exclusive US commercial rights to alv...
Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surg...
The centre is expected to be operational in 2027 and will join Amgen’s global R...
The agreement covers US commercial and global manufacturing rights to Mereo Bio...
Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for bu...
The deal includes joint studies combining BeOne’s cancer pipeline assets with fo...